BACKGROUND: Hypercholesterolemia causes alterations in platelet function. Platelet hyperaggregation is considered a predisposing factor for atherosclerosis. In this paper, the antiaggregating effect of the polyamines putrescine, spermidine, and spermine was studied on platelets of normal and hypercholesterolemic rabbits. METHODS: New Zealand rabbits were fed with a cholesterol-enriched diet for 10 weeks. Lipids and glucose were determined in serum. The assays of platelet aggregation were carried out using platelet-rich plasma (PRP) obtained from both control and cholesterol-fed rabbits. We used 2.5 micromol /mL ADP and 2 microg/mL collagen as inductors of platelet aggregation. In addition, arginase activity and L-arginine content were determined in PRP. RESULTS: Serum total cholesterol and LDL-cholesterol concentrations were increased from 26.3 +/- 8.1 to 1,485.0 +/- 26.8 mg/dL and from 15.9 +/- 5.9 to 1,383.8 +/- 58.9 mg/dL, respectively, whereas triglyceride concentration increased from 88.3 +/- 35.6 to 411.0 +/- 154.5 mg/dL upon cholesterol feeding. Seventy-five percent of platelet aggregation inhibition was observed with 10 microM of polyamines in PRP of normal rabbits. Spermine inhibited platelet aggregation by 54% in PRP of hypercholesterolemic rabbits when ADP was used as agonist. The order of polyamine action was spermine > spermidine > putrescine. In addition, we found that platelet arginase activity and L-arginine content were unaltered upon hypercholesterolemia. CONCLUSIONS: These results show that the polyamines putrescine, spermidine, and spermine have antagonist action in platelet aggregation and suggest a key role of polyamines in platelet aggregation under normal and hypercholesterolemic conditions.
BACKGROUND:Hypercholesterolemia causes alterations in platelet function. Platelet hyperaggregation is considered a predisposing factor for atherosclerosis. In this paper, the antiaggregating effect of the polyaminesputrescine, spermidine, and spermine was studied on platelets of normal and hypercholesterolemic rabbits. METHODS:New Zealand rabbits were fed with a cholesterol-enriched diet for 10 weeks. Lipids and glucose were determined in serum. The assays of platelet aggregation were carried out using platelet-rich plasma (PRP) obtained from both control and cholesterol-fed rabbits. We used 2.5 micromol /mL ADP and 2 microg/mL collagen as inductors of platelet aggregation. In addition, arginase activity and L-arginine content were determined in PRP. RESULTS: Serum total cholesterol and LDL-cholesterol concentrations were increased from 26.3 +/- 8.1 to 1,485.0 +/- 26.8 mg/dL and from 15.9 +/- 5.9 to 1,383.8 +/- 58.9 mg/dL, respectively, whereas triglyceride concentration increased from 88.3 +/- 35.6 to 411.0 +/- 154.5 mg/dL upon cholesterol feeding. Seventy-five percent of platelet aggregation inhibition was observed with 10 microM of polyamines in PRP of normal rabbits. Spermine inhibited platelet aggregation by 54% in PRP of hypercholesterolemic rabbits when ADP was used as agonist. The order of polyamine action was spermine > spermidine > putrescine. In addition, we found that platelet arginase activity and L-arginine content were unaltered upon hypercholesterolemia. CONCLUSIONS: These results show that the polyaminesputrescine, spermidine, and spermine have antagonist action in platelet aggregation and suggest a key role of polyamines in platelet aggregation under normal and hypercholesterolemic conditions.
Authors: Angelo D'alessandro; Travis Nemkov; Hunter B Moore; Ernest E Moore; Matthew Wither; Trevor Nydam; Annie Slaughter; Christopher C Silliman; Anirban Banerjee; Kirk C Hansen Journal: Blood Transfus Date: 2016-04-22 Impact factor: 3.443
Authors: H B Moore; E E Moore; M P Chapman; E Gonzalez; A L Slaughter; A P Morton; A D'Alessandro; K C Hansen; A Sauaia; A Banerjee; C C Silliman Journal: J Thromb Haemost Date: 2015-09-22 Impact factor: 5.824
Authors: Stephanie A Smith; Sharon H Choi; Julie N R Collins; Richard J Travers; Brian C Cooley; James H Morrissey Journal: Blood Date: 2012-09-11 Impact factor: 22.113
Authors: Joana P Bernardes; Neha Mishra; Florian Tran; Thomas Bahmer; Lena Best; Johanna I Blase; Dora Bordoni; Jeanette Franzenburg; Ulf Geisen; Jonathan Josephs-Spaulding; Philipp Köhler; Axel Künstner; Elisa Rosati; Anna C Aschenbrenner; Petra Bacher; Nathan Baran; Teide Boysen; Burkhard Brandt; Niklas Bruse; Jonathan Dörr; Andreas Dräger; Gunnar Elke; David Ellinghaus; Julia Fischer; Michael Forster; Andre Franke; Sören Franzenburg; Norbert Frey; Anette Friedrichs; Janina Fuß; Andreas Glück; Jacob Hamm; Finn Hinrichsen; Marc P Hoeppner; Simon Imm; Ralf Junker; Sina Kaiser; Ying H Kan; Rainer Knoll; Christoph Lange; Georg Laue; Clemens Lier; Matthias Lindner; Georgios Marinos; Robert Markewitz; Jacob Nattermann; Rainer Noth; Peter Pickkers; Klaus F Rabe; Alina Renz; Christoph Röcken; Jan Rupp; Annika Schaffarzyk; Alexander Scheffold; Jonas Schulte-Schrepping; Domagoj Schunk; Dirk Skowasch; Thomas Ulas; Klaus-Peter Wandinger; Michael Wittig; Johannes Zimmermann; Hauke Busch; Bimba F Hoyer; Christoph Kaleta; Jan Heyckendorf; Matthijs Kox; Jan Rybniker; Stefan Schreiber; Joachim L Schultze; Philip Rosenstiel Journal: Immunity Date: 2020-11-26 Impact factor: 31.745
Authors: Marta Martin-Lorenzo; Irene Zubiri; Aroa S Maroto; Laura Gonzalez-Calero; Maria Posada-Ayala; Fernando de la Cuesta; Laura Mourino-Alvarez; Luis F Lopez-Almodovar; Eva Calvo-Bonacho; Luis M Ruilope; Luis R Padial; Maria G Barderas; Fernando Vivanco; Gloria Alvarez-Llamas Journal: Metabolomics Date: 2014-12-14 Impact factor: 4.290